Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Ethnopharmacology|April 17, 2014
Hugan Qingzhi medication ameliorates hepatic steatosis by activating AMPK and PPARα pathways in L02 cells and HepG2 cellsJinJin Yin, YanQin Luo, HouLiang Deng, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|November 28, 2016
Alisol A 24-Acetate Prevents Hepatic Steatosis and Metabolic Disorders in HepG2 CellsLu Zeng, WaiJiao Tang, JinJin Yin, et al.
BMC Complementary Medicine and Therapies|December 14, 2020
Hugan Qingzhi medication ameliorates free fatty acid-induced L02 hepatocyte endoplasmic reticulum stress by regulating the activation of PKC-δMiaoting Yang, Zhijuan Chen, Shijian Xiang, et al.
Oxidative Medicine and Cellular Longevity|January 24, 2019
Modulation of the Gut Microbiota in Rats by Hugan Qingzhi Tablets during the Treatment of High-Fat-Diet-Induced Nonalcoholic Fatty Liver DiseaseWaijiao Tang, Xiaorui Yao, Fan Xia, et al.
Nutrients|November 26, 2022
Polyphenol-Rich Liupao Tea Extract Prevents High-Fat Diet-Induced MAFLD by Modulating the Gut MicrobiotaWaijiao Tang, Mengfei Yuan, Zewen Li, et al.
Current Neuropharmacology|May 15, 2026
Serum Cyclic Pentapeptide Cyclo(D-Trp-D-Asp-Pro-D-Val-Leu) as a Candidate Diagnostic Biomarker for Depression-Anxiety ComorbidityYan Zhen, Zezhi Li, Zelin Li, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|July 7, 2015
Hugan Qingzhi Exerts Anti-Inflammatory Effects in a Rat Model of Nonalcoholic Fatty Liver DiseaseWaiJiao Tang, Lu Zeng, JinJin Yin, et al.
Briefings in Bioinformatics|March 15, 2024
metaProbiotics: a tool for mining probiotic from metagenomic binning data based on a language modelShufang Wu, Tao Feng, Waijiao Tang, et al.
Ultrasonics Sonochemistry|October 21, 2023
Ultrasonic effects on the degradation kinetics, structural characteristics and protective effects on hepatocyte lipotoxicity induced by palmitic acid of Pueraria Lobata polysaccharidesZuman Dou, Yulong Zhang, Waijiao Tang, et al.
Iscience|January 26, 2026
Gut microbiota and Parkinson's disease: exploring pathogenesis and potential therapeutic strategies from a gut-brain axis perspectiveXiayu Jin, Jirui Wei, Xudong Min, et al.
Pageof 3